Skip to main content
Clinical Trials/CTRI/2023/09/057518
CTRI/2023/09/057518
Not yet recruiting
未知

Genetic Analysis of Ophthalmologic Disorders - NI

Strand Life Sciences Private Limited0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: H353- Degeneration of macula and posterior poleHealth Condition 2: H40- GlaucomaHealth Condition 3: E113- Type 2 diabetes mellitus with ophthalmic complications
Sponsor
Strand Life Sciences Private Limited
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Individuals with a confirmed diagnosis of one or more of the above diseases, along with adequate supporting clinical information (age at onset, diagnostic methods, details of disease progression, underlying medical history, phenotypic characteristics and associated SOC test results)
  • 2\.Familial cases with access to affected family members is desired
  • 3\.Ability to understand the purpose of the study and willingness to sign an Informed Consent Form
  • 4\.Willingness to provide 13\-23 mL of blood
  • 5\.Tear sample (if available and possible) may be collected for DR and AMD cases only
  • 6\.Willingness to be contacted in future for recording health updates.

Exclusion Criteria

  • 1\.Individuals with chronic uncontrolled infection
  • 2\.Individuals with any acute illness or infection
  • 3\.Pregnant and lactating women.

Outcomes

Primary Outcomes

Not specified

Similar Trials